This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 24/7/1259    most recent 01.ATV.0000133192.39901.bev1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cipollone, F. Articles by Mezzetti, A. Search for Related Content PubMed PubMed Citation Articles by Cipollone, F. Articles by Mezzetti, A. Related Collections Pathophysiology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1259.)
© 2004 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Balance Between PGD Synthase and PGE Synthase Is a Major Determinant of Atherosclerotic Plaque Instability in Humans

Francesco Cipollone; Maria Fazia; Annalisa Iezzi; Giovanni Ciabattoni; Barbara Pini; Chiara Cuccurullo; Sante Ucchino; Francesco Spigonardo; Mariella De Luca; Cesaria Prontera; Francesco Chiarelli; Franco Cuccurullo; Andrea Mezzetti

From the Atherosclerosis Prevention Center (F.C., M.F., A.I., B.P., C.C., C.P., F.Chiarelli, F.Cuccurullo, A.M.), and the Department of Experimental and Clinical Surgery (S.U., F.S., M.D.L.), University of Chieti "G D’Annunzio," School of Medicine, and the Department of Drug Science (G.C.), University of Chieti "G D’Annunzio," School of Pharmacy; Chieti, Italy.

Correspondence to Francesco Cipollone, Centro Regionale per la Prevenzione dell’Aterosclerosi, Centro per lo Studio dell’Invecchiamento (Ce.S.I.), Via Colle dell’Ara, 66013 Chieti, Italy. E-mail fcipollone{at}unich.it

Objective— Inducible cyclooxygenase (COX-2) catalyzes the first step in prostanoid biosynthesis and is considered a proinflammatory enzyme. COX-2 and type 1 inducible PGE synthase (mPGES-1) have a role in metalloproteinase (MMP) release leading to plaque rupture. In contrast, lipocalin-type PGD synthase (L-PGDS) has been shown to exert antiinflammatory actions. Thus, in this study we investigated whether a shift from a PGDS-oriented to a PGES-oriented profile in arachidonate metabolism leads to inflammatory activation in rupture-prone plaque macrophages.

Methods and Results— Atherosclerotic plaques were obtained from 60 patients who underwent carotid endarterectomy, symptomatic (n=30) and asymptomatic (n=30) according to evidence of recent transient ischemic attack or stroke. Plaques were analyzed for COX-2, mPGES-1, L-PGDS, PPAR, IB, NF-B, and MMP-9 by immunocytochemistry, Western blot, reverse-transcriptase polymerase chain reaction, enzyme immunoassay, and zymography. Prostaglandin E₂ (PGE₂) pathway was significantly prevalent in symptomatic plaques, whereas PGD₂ pathway was overexpressed in asymptomatic ones, associated with NF-B inactivation and MMP-9 suppression. In vitro COX-2 inhibition in monocytes was associated with reduced MMP-9 release only when PGD₂ pathway overcame PGE₂ pathway.

Conclusions— These results suggest that COX-2 may have proinflammatory and antiinflammatory properties as a function of expression of downstream PGH₂ isomerases, and that the switch from L-PGDS to mPGES-1 in plaque macrophages is associated with cerebral ischemic syndromes, possibly through MMP-induced plaque rupture.

The aim of this study was to investigate whether the balance between PGD synthase and PGE synthase activity in macrophages could influence the evolution of human atherosclerotic plaque toward instability. Results clearly demonstrate that COX-2 may have proinflammatory or antiinflammatory properties as a function of downstream PGH₂ isomerases expression.

Key Words: COX-2 • PGE synthase • PGD synthase • metalloproteinase • plaque rupture

This article has been cited by other articles:

				M Korotkova, S B. Helmers, I Loell, H Alexanderson, C Grundtman, C Dorph, I E Lundberg, and P-J Jakobsson Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis Ann Rheum Dis, November 1, 2008; 67(11): 1596 - 1602. [Abstract] [Full Text] [PDF]

				R. S. Deeb, R. K. Upmacis, B. D. Lamon, S. S. Gross, and D. P. Hajjar Maintaining Equilibrium by Selective Targeting of Cyclooxygenase Pathways: Promising Offensives Against Vascular Injury Hypertension, January 1, 2008; 51(1): 1 - 7. [Full Text] [PDF]

				M. Joo, M. Kwon, R. T. Sadikot, P. J. Kingsley, L. J. Marnett, T. S. Blackwell, R. S. Peebles Jr, Y. Urade, and J. W. Christman Induction and Function of Lipocalin Prostaglandin D Synthase in Host Immunity J. Immunol., August 15, 2007; 179(4): 2565 - 2575. [Abstract] [Full Text] [PDF]

				M. W. Buczynski, D. L. Stephens, R. C. Bowers-Gentry, A. Grkovich, R. A. Deems, and E. A. Dennis TLR-4 and Sustained Calcium Agonists Synergistically Produce Eicosanoids Independent of Protein Synthesis in RAW264.7 Cells J. Biol. Chem., August 3, 2007; 282(31): 22834 - 22847. [Abstract] [Full Text] [PDF]

				K. Fujimori, K. Aritake, and Y. Urade A Novel Pathway to Enhance Adipocyte Differentiation of 3T3-L1 Cells by Up-regulation of Lipocalin-type Prostaglandin D Synthase Mediated by Liver X Receptor-activated Sterol Regulatory Element-binding Protein-1c J. Biol. Chem., June 22, 2007; 282(25): 18458 - 18466. [Abstract] [Full Text] [PDF]

				H. Vunta, F. Davis, U. D. Palempalli, D. Bhat, R. J. Arner, J. T. Thompson, D. G. Peterson, C. C. Reddy, and K. S. Prabhu The Anti-inflammatory Effects of Selenium Are Mediated through 15-Deoxy-{Delta}12,14-prostaglandin J2 in Macrophages J. Biol. Chem., June 22, 2007; 282(25): 17964 - 17973. [Abstract] [Full Text] [PDF]

				A. Habib, I. Shamseddeen, M. S. Nasrallah, T. A. Antoun, G. Nemer, J. Bertoglio, R. Badreddine, and K. F. Badr Modulation of COX-2 expression by statins in human monocytic cells FASEB J, June 1, 2007; 21(8): 1665 - 1674. [Abstract] [Full Text] [PDF]

				D R Harding, S E Humphries, A Whitelaw, N Marlow, and H E Montgomery Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infant Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2007; 92(2): F108 - F112. [Abstract] [Full Text] [PDF]

				S. Gross, P. Tilly, D. Hentsch, J.-L. Vonesch, and J.-E. Fabre Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors J. Exp. Med., February 19, 2007; 204(2): 311 - 320. [Abstract] [Full Text] [PDF]

				J. Hallenbeck, G. del Zoppo, T. Jacobs, A. Hakim, S. Goldman, U. Utz, A. Hasan, and for the Immunomodulation Workshop Participants Immunomodulation Strategies for Preventing Vascular Disease of the Brain and Heart: Workshop Summary Stroke, December 1, 2006; 37(12): 3035 - 3042. [Abstract] [Full Text] [PDF]

				D. Versari, J. Herrmann, M. Gossl, D. Mannheim, K. Sattler, F. B. Meyer, L. O. Lerman, and A. Lerman Dysregulation of the Ubiquitin-Proteasome System in Human Carotid Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2132 - 2139. [Abstract] [Full Text] [PDF]

				J.N.E. Redgrave, J.K. Lovett, P.J. Gallagher, and P.M. Rothwell Histological Assessment of 526 Symptomatic Carotid Plaques in Relation to the Nature and Timing of Ischemic Symptoms: The Oxford Plaque Study Circulation, May 16, 2006; 113(19): 2320 - 2328. [Abstract] [Full Text] [PDF]

				B. Rocca Targeting PGE2 Receptor Subtypes Rather Than Cyclooxygenases: A Bridge Over Troubled Water? Mol. Interv., April 1, 2006; 6(2): 68 - 73. [Abstract] [Full Text] [PDF]

				S. Pavlovic, B. Du, K. Sakamoto, K. M. F. Khan, C. Natarajan, R. M. Breyer, A. J. Dannenberg, and D. J. Falcone Targeting Prostaglandin E2 Receptors as an Alternative Strategy to Block Cyclooxygenase-2-dependent Extracellular Matrix-induced Matrix Metalloproteinase-9 Expression by Macrophages J. Biol. Chem., February 10, 2006; 281(6): 3321 - 3328. [Abstract] [Full Text] [PDF]

				F Cipollone COX-2 and prostaglandins in atherosclerosis Lupus, September 1, 2005; 14(9): 756 - 759. [Abstract] [PDF]

				F. Cipollone, M. L. Fazia, A. Iezzi, C. Cuccurullo, D. De Cesare, S. Ucchino, F. Spigonardo, A. Marchetti, F. Buttitta, L. Paloscia, et al. Association Between Prostaglandin E Receptor Subtype EP4 Overexpression and Unstable Phenotype in Atherosclerotic Plaques in Human Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1925 - 1931. [Abstract] [Full Text] [PDF]

				L. Ragolia, T. Palaia, C. E. Hall, J. K. Maesaka, N. Eguchi, and Y. Urade Accelerated Glucose Intolerance, Nephropathy, and Atherosclerosis in Prostaglandin D2 Synthase Knock-out Mice J. Biol. Chem., August 19, 2005; 280(33): 29946 - 29955. [Abstract] [Full Text] [PDF]

				M. Miyagi, Y. Miwa, F. Takahashi-Yanaga, S. Morimoto, and T. Sasaguri Activator Protein-1 Mediates Shear Stress-Induced Prostaglandin D Synthase Gene Expression in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 970 - 975. [Abstract] [Full Text] [PDF]

				G. Giannico, M. Mendez, and M. C. LaPointe Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H165 - H174. [Abstract] [Full Text] [PDF]